{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:14Z","timestamp":1791348614748,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtho.2026.104176","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:36:22Z","timestamp":1788190582000},"page":"104176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA and RNA EGFR Variant Allele Fractions and Clinical Outcomes in Lung Adenocarcinoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-5305","authenticated-orcid":false,"given":"Rodrigo","family":"Espinoza Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.W.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsao-Hsun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie P.L.","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Jacobsen","family":"Skanderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Chyr","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.104176_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ccell.2025.07.011","article-title":"Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures","volume":"43","author":"Satpathy","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104176_bib2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jtho.2016.08.142","article-title":"Comprehensive characterization of oncogenic drivers in Asian Lung adenocarcinoma","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104176_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1398","article-title":"Genetic profile of non-small cell lung cancer (NSCLC): a hospital-based survey in Jinhua","volume":"8","author":"Chen","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jtho.2026.104176_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","article-title":"Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2026.104176_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4046\/trd.2022.0081","article-title":"Update on adjuvant treatment in resectable non-small cell lung cancer and potential biomarkers predicting postoperative relapse","volume":"86","author":"Lim","year":"2023","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.jtho.2026.104176_bib6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.18632\/oncotarget.27602","article-title":"The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy","volume":"11","author":"Galvez","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2026.104176_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jtho.2023.10.001","article-title":"Co-occurring alterations in multiple tumor suppressor genes are associated with worse outcomes in patients with EGFR-mutant lung cancer","volume":"19","author":"Stockhammer","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104176_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/cancers15030629","article-title":"Treatment strategies for non-small cell lung cancer with common EGFR mutations: a review of the history of EGFR TKIs approval and emerging data","volume":"15","author":"Marin-Acevedo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.104176_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1186\/s12885-018-4849-9","article-title":"Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery","volume":"18","author":"Isaka","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41588-019-0569-6","article-title":"Genomic landscape of lung adenocarcinoma in East Asians","volume":"52","author":"Chen","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2026.104176_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jtcvs.2020.05.099","article-title":"Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma","volume":"162","author":"Deng","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.104176_bib12","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/1759-7714.12866","article-title":"Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma","volume":"9","author":"Ito","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.lungcan.2020.01.018","article-title":"Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: a retrospective multi-center analysis","volume":"141","author":"Ito","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib14","article-title":"Patients with Exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2026.104176_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41467-017-02584-z","article-title":"Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing","volume":"9","author":"Nahar","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2026.104176_bib16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2026.104176_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107352","article-title":"Whole exome sequencing and microRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages","volume":"184","author":"Ho","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3892\/mco.2025.2857","article-title":"Molecular mechanisms and therapeutic strategies for small-cell lung cancer transformation after TKI therapy in EGFR-mutated lung adenocarcinoma","volume":"23","author":"Zhang","year":"2025","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104176_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145099","article-title":"Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer","volume":"132","author":"Nanjo","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtho.2026.104176_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.lungcan.2016.10.015","article-title":"Coexistence of p16\/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs","volume":"102","author":"Jiang","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/bjc.2016.22","article-title":"Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients","volume":"114","author":"Martin","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib22","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/annonc\/mdu251","article-title":"Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation","volume":"25","author":"Ono","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.104176_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.trecan.2023.08.011","article-title":"Variant allele frequency: a decision-making tool in precision oncology?","volume":"9","author":"Boscolo Bielo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib24","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/jnci\/djae160","article-title":"Genomic instability in non-breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1\/2","volume":"116","author":"Elze","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2026.104176_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13059-025-03557-y","article-title":"Cancer gene identification from RNA variant allelic frequencies using RVdriver","volume":"26","author":"Black","year":"2025","journal-title":"Genome Biol"},{"key":"10.1016\/j.jtho.2026.104176_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.00043511","article-title":"RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer","volume":"39","author":"Tsai","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2026.104176_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31892","article-title":"Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor-positive non-small cell lung cancer","volume":"4","author":"Saw","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtho.2026.104176_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.jtho.2026.104176_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtho.2026.104176_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104176_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtho.2026.104176_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s42003-023-04764-8","article-title":"PUREE: accurate pan-cancer tumor purity estimation from gene expression data","volume":"6","author":"Revkov","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jtho.2026.104176_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2017.06.014","article-title":"Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)","volume":"111","author":"Labb\u00e9","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib34","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2026.104176_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41416-023-02288-w","article-title":"Clinical biomarker-based biological aging and risk of cancer in the UK Biobank","volume":"129","author":"Mak","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2026.104176_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.0006-341X.2001.00114.x","article-title":"A solution to the problem of monotone likelihood in Cox regression","volume":"57","author":"Heinze","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.jtho.2026.104176_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jtho.2026.104176_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-9473(02)00225-6","article-title":"On the exact distribution of maximally selected rank statistics","volume":"43","author":"Hothorn","year":"2003","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/j.jtho.2026.104176_bib39","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtho.2026.104176_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41598-017-18560-y","article-title":"Impact of concurrent genomic alterations detected by comprehensive genomic sequencing on clinical outcomes in East-Asian patients with EGFR-mutated lung adenocarcinoma","volume":"8","author":"Sato","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2026.104176_bib41","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1158\/1078-0432.CCR-22-0879","article-title":"Clinical, pathologic, and molecular prognostic factors in patients with early-stage EGFR-mutant NSCLC","volume":"28","author":"Jung","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104176_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2018.12.001","article-title":"Oncogene addiction as a foundation of targeted cancer therapy: the paradigm of the MET receptor tyrosine kinase","volume":"443","author":"Orlando","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtho.2026.104176_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtho.2026.104176_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jtho.2026.104176_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtho.2026.104176_bib46","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/0008-5472.CAN-06-3339","article-title":"Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification","volume":"67","author":"Okabe","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2026.104176_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR-mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2026.104176_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002356","article-title":"Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling","volume":"3","author":"Chmielecki","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2026.104176_bib49","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1158\/0008-5472.CAN-18-3652","article-title":"Patient-specific tumor growth trajectories determine persistent and resistant cancer cell populations during treatment with targeted therapies","volume":"79","author":"Grassberger","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2026.104176_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7212","article-title":"Measuring competitive exclusion in non-small cell lung cancer","volume":"8","author":"Farrokhian","year":"2022","journal-title":"Sci Adv"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426006295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426006295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:56:53Z","timestamp":1791345413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086426006295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S1556086426006295"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104176","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA and RNA EGFR Variant Allele Fractions and Clinical Outcomes in Lung Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104176"}}